Risk for specific hematologic cancers down with GLP-1 receptor agonist use in type 2 diabetes
For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...
Infectious Disease Advisor1d
No Link Seen Between Preoperative GLP-1 RA Use and Postoperative Aspiration Pneumonia
Preoperative glucagon-like peptide-1 receptor agonist use is not associated with short-term postoperative aspiration pneumonia.
Stopping GLP-1 RAs 14 days before surgery can minimize complications
Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...
Endocrinology Advisor17h
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonist use is associated with a reduced risk for developing hematologic cancers compared with insulin and metformin use.
HealthDay on MSN2d
AAOS: Stopping GLP-1 RAs 14 Days Before Surgery Can Minimize Complications
Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can m ...
Endocrinology Advisor1d
GLP-1 Drugs Associated With a Reduced Risk of Multiple Age-Related Ocular Diseases
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
Monthly Prescribing Reference2d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...
MPR6d
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia
No significant difference seen in odds of postoperative pneumonia between adult GLP-1 receptor agonist users and nonusers.
The Cardiology Advisor2d
GLP-1 Receptor Agonists May Have Broader Range of Benefits, Risks
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...